Among them, 4 and 8 patients experienced severe OHSS, 28 and 29 experienced moderate OHSS, and 59 and 35 experienced mild OHSS in those who received GnRH-antag and GnRH-a, respectively. The gene discussed is GNRH1; the disease is ovarian hyperstimulation syndrome.